Viva Biotech Holdings (VBIZF)
OTCMKTS
· Delayed Price · Currency is USD
0.2420
+0.0231 (10.55%)
At close: May 27, 2025
Viva Biotech Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 23, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Market Capitalization | 478 | 234 | 288 | 430 | 1,160 | 2,256 | Upgrade
|
| Market Cap Growth | -18.73% | -18.73% | -33.03% | -62.94% | -48.59% | 146.75% | Upgrade
|
| Enterprise Value | 527 | 306 | 541 | 745 | 1,346 | 2,058 | Upgrade
|
| Last Close Price | 0.24 | 0.07 | 0.12 | 0.24 | 0.60 | 1.20 | Upgrade
|
| PE Ratio | 20.87 | 10.21 | - | - | 25.63 | - | Upgrade
|
| PS Ratio | 1.76 | 0.86 | 0.95 | 1.25 | 3.50 | 21.13 | Upgrade
|
| PB Ratio | 0.91 | 0.45 | 0.55 | 0.82 | 1.88 | 3.92 | Upgrade
|
| P/TBV Ratio | 2.73 | 1.33 | 1.84 | 3.05 | 6.01 | 10.23 | Upgrade
|
| P/FCF Ratio | 19.05 | 9.32 | 10.43 | 21.69 | - | - | Upgrade
|
| P/OCF Ratio | 9.34 | 4.57 | 5.32 | 7.68 | 94.67 | 341.11 | Upgrade
|
| EV/Sales Ratio | 1.95 | 1.12 | 1.78 | 2.16 | 4.06 | 19.28 | Upgrade
|
| EV/EBITDA Ratio | 8.76 | 5.16 | 9.81 | 11.78 | 23.11 | 81.76 | Upgrade
|
| EV/EBIT Ratio | 16.92 | 9.71 | 19.92 | 19.32 | 36.09 | 119.41 | Upgrade
|
| EV/FCF Ratio | 20.97 | 12.17 | 19.61 | 37.58 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.34 | 0.52 | 0.78 | 0.68 | 0.79 | Upgrade
|
| Debt / EBITDA Ratio | 2.90 | 2.90 | 4.71 | 6.25 | 6.81 | 16.25 | Upgrade
|
| Debt / FCF Ratio | 7.01 | 7.01 | 9.72 | 20.65 | - | - | Upgrade
|
| Asset Turnover | 0.27 | 0.27 | 0.28 | 0.30 | 0.26 | 0.14 | Upgrade
|
| Inventory Turnover | 4.88 | 4.88 | 4.84 | 5.61 | 7.33 | 4.53 | Upgrade
|
| Quick Ratio | 1.26 | 1.26 | 1.03 | 0.44 | 1.44 | 3.75 | Upgrade
|
| Current Ratio | 1.67 | 1.67 | 1.32 | 0.73 | 2.14 | 4.56 | Upgrade
|
| Return on Equity (ROE) | 5.92% | 5.92% | -2.74% | -13.41% | 7.84% | -13.69% | Upgrade
|
| Return on Assets (ROA) | 1.98% | 1.98% | 1.57% | 2.08% | 1.83% | 1.40% | Upgrade
|
| Return on Capital (ROIC) | 2.69% | 2.69% | 2.00% | 2.56% | 2.23% | 1.65% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.90% | 3.30% | 5.10% | 3.30% | 1.50% | Upgrade
|
| Earnings Yield | 4.79% | 9.80% | -5.69% | -17.82% | 3.90% | -2.63% | Upgrade
|
| FCF Yield | 5.25% | 10.73% | 9.59% | 4.61% | -6.61% | -3.73% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.30% | Upgrade
|
| Payout Ratio | - | - | - | - | 5.66% | - | Upgrade
|
| Buyback Yield / Dilution | -41.39% | -41.39% | -5.91% | 2.81% | -25.41% | -5.83% | Upgrade
|
| Total Shareholder Return | -41.39% | -41.39% | -5.91% | 2.81% | -25.41% | -5.53% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.